Articles On Monash IVF Group (ASX:MVF)

The Healthcare sector has been struggling as the pandemic wanes But most money managers are still bullish on the sector The biggest movements and news from ASX healthcare stocks this week  Dr Anthony Faucci, America’s top infectious disea...

The ASX healthcare sector rebounds on back of $20 billion Ramsay Healthcare takeover bid Volpara founder and CEO steps into new role as female CEO takes the reins Medlab Clinical shares soar after UK trade deal for probiotic for patients...

The healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak market appetite  A snapshot of the return of recent ASX Healthcare IPO stocks We are currently in the longest and steepest bear market for biot...

S&P/ASX 200 healthcare index modestly up 0.16% for week Gut health company Microba falls on IPO Rhythm Biosciences bowel cancer blood screening test milestone Have a habit of forgetting where you put your keys or mobile phone? You ma...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in ASX health stocks. Good news for coffee lovers, particularly those w...

Biotech sector has had a tough time recently But there are signs of things improving this year A look at biotech movers on the ASX in the past fortnight Biotech stocks entered a bear phase in the middle of 2021, and things haven’t improve...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Through the destruction of war...

Telehealth was already a growing space even before the pandemic, but COVID had launched it into the mainstream. At the height of the pandemic in 2020, data from Research and Markets showed that 76% of hospitals in the US were using teleheal...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. First a note on things are are...

Highlights The ASX 200 surged 0.61% to 7,316.7 in the first 15 minutes of trade. Gold prices rose on Wednesday after NATO and the US stated that Russia was deploying more troops near Ukraine border. The IT space has tumbled 2.13% so f...

At the time of writing, the ASX 200 Health Index (XHJ) is up by another 3.3%, while the benchmark ASX 200 has risen by 0.5%. Cancer and fibrosis focused biotech Amplia Therapeutics (ASX:ATX) said its AMP945 drug improves effectiveness of cu...

The ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial turn in the courts this week. The healthcare giant is currently staring down 38,000 claims that its talc products (including the famous baby...

It’s an exciting day for owners of these ASX small-cap shares – they’re hitting their highest share price in years. Shares in both Monash IVF Group Ltd (ASX: MVF) and Maggie Beer Holdings Ltd (ASX: MBH) are revelling in reporting season. T...

We go over the key stocks we are looking out for in the Healthcare sector this February Reporting Season. Stocks include; ResMed Inc (ASX:RMD), Pro Medicus (ASX:PME), Healius (ASX:HLS), Virtus Health (ASX:VRT), Monash IVF (ASX:MVF), and CSL...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Here’s something for anyone who...

Key points The Monash IVF share price has lifted nearly 6% today It comes after COVID-19 IVF restrictions were lifted in Victoria The company will resume IVF services next week The Monash IVF Group Ltd (ASX: MVF) share price is ri...

Following new health orders in Victoria, Monash IVF Group (MVF) says non-urgent surgery protocols will disrupt some IVF procedures in Melbourne and other major centres The group says patients who plan to commence a stimulated cycle after J...

At the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, beating the ASX200 benchmark index which was up 2.8% for the period. Here’s a table showing how ASX-listed healthcare stocks have been perform...

It’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. CODE COMPANY PRICE 1 WEEK RETURN %...

MoneyTalks is Stockhead’s regular recap of the stocks, sectors and trends that ASX fund managers and analysts are looking at right now and into 2022. Today we hear from Julian Guido from Perennial Partners‘ Value Smaller Companies Trust whe...

An ASX company sometimes buys back its own shares, as a way to return capital to investors. Such actions are not necessarily received well, according to Allan Gray portfolio manager Dr Suhas Nayak. “Some argue that it shows a lack of growt...

SYDNEY, Dec. 9, 2021 /PRNewswire/ — Irongate Group (ASX: IAP; JSE: IAP) has today announced the acquisition of an industrial business park in Perth, the acquisition of an A-grade office building in Melbourne and a fully underwritten institu...

It’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 losing it and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Name Price % Six Mont...

It’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 losing it and 16 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Company Price % Six M...

ShareCafeMVF – Macquarie rates the stock as Outperform Macquarie raises FY22-4 EPS forecasts by 2% for Monash IVF Group following a 1Q trading update and 1H22 profit guidance which was a 5% beat versus the broker’s forecast. The target pric...

A downbeat week leaned towards a lacklustre conclusion following a mixed finish on Wall Street as investors weighed corporate earnings, lingering rates worries and a seasonal uptick in Covid cases. ASX futures edged up eight points or 0....

Australian shares looked set to start a new week little changed as a recovery in the dollar and declines in key commodities offset gains on Wall Street. ASX futures eased three points or 0.04 per cent, signalling a flat start following F...

History shows that shortly after catastrophic events end, the world experiences a baby boom. “When large mortality events occur including diseases, earthquakes, and wars, birth rates decline and on average, reach a trough some 9 months lat...

In this week's Weekly Insights:-Forecasts Are Falling-Conviction Calls-Research To DownloadBy Rudi Filapek-Vandyck, Editor FNArenaForecasts Are FallingAs if investors didn't already have enough to worry about, earnings forecasts around the...

Brokers are always on the search for ASX share opportunities that may be good ideas to consider. Businesses are regularly updating the market and conditions are changing. Add in that fact that share prices are changing as well and investor...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week At the time...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Theme of the week The Healthcar...

Although earnings results were the main theme in August, there were also some notable healthcare breakthroughs on the ASX. Dimerix (ASX:DXB) jumped 45% during the month after announcing the commencement of ACTION 3, a Phase III study in pat...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week Healthcare...

Today, Wednesday the 25th of August, we are happy to buy Ansell (ASX:ANN), HUB24 Ltd (ASX:HUB), Superloop (ASX:SLC), Aerometrex Limited (ASX:AMX), Monash IVF Group Ltd (ASX:MVF), Virtus Health Ltd (ASX:VRT) and Viva Energy Group (ASX:VEA).

The Monash IVF Group Ltd (ASX: MVF) share price is gaining in intraday trade, up 3% to 99 cents per share. This follows on the release of the reproductive services provider’s results for the 2021 financial year ending 30 June (FY21). Monas...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week Healthcare...

It’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 76 losing it and 23 flatlining. Rhinomed (ASX:RNO) was the biggest gainer, up a massive 85% for the fortnight after scoring a contract with N...

The ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the XHJ Health Sector and the ASX 200 benchmark rose by 3% over this period. A handful of ASX health stocks have seen their prices skyrocket du...

There are a small number of ASX shares that many brokers like at the same time. It might indicate that there is an opportunity with these businesses because brokers are constantly on the lookout for ideas. If they all like a company, then...

It’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 74 losing it and 21 flatlining. Analytica Limited (ASX:ALT) was the biggest gainer, up 25% from 8 to 20 July, followed by  Rhinomed (ASX:RNO)...

Fortunately, in this low interest rate environment, there are countless dividend shares for investors to choose from on the Australian share market. But with so many to choose from, it can be hard to decide which ones to buy. To narrow thi...

Summary The S&P/ASX200 declined as much as 0.3% to hit a low of 7,316. Six of the 11 sectors were trading lower, while tech and energy were among top laggards. Shares of Rio Tinto fell over 1% after the global miner raised iron or...

It’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52 losing it – and 21 flatlining. Botanix Pharma Ltd (ASX:BOT) was the biggest gainer, up 38% from 23 June to 7 July, and Suda Pharmaceuticals...

Here’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has returned 2.3 per cent for the last two weeks, compared to the broader market which rose by 2.7 per cent. The biggest news globally was out of U...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week Healthcare...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week Healthcare...

You might think ASX healthcare shares would be among the most insulated from the digital disruption, but that view doesn’t gel with all experts. In fact, some are predicting that the healthcare sector could be next to be shaken by the digi...

Summary Neurotech International has commenced Phase I/II open-label clinical trial in children having Autism Spectrum Disorder. Multinational pharmaceutical company AFT Pharmaceuticals disclosed the extension of licensing of Maxigesic®...

On Wednesday I looked at three ASX shares that brokers have given buy ratings to this week. Unfortunately, not all shares are in favour with them right now. Three ASX shares that have just been given sell ratings by brokers are listed belo...